REFERENCES
- Bourdeaut F, Fréneaux P, Thuille B, et al. Extra-renal non-cerebral rhabdoid tumours. Pediatr Blood Cancer. 2008;51(3):363–368.
- Brennan B, Stiller C, Bourdeaut F. Extracranial rhabdoid tumours: what we have learned so far and future directions. Lancet Oncol. 2013;14(8):329–336.
- Garcés-Iñigo EF, Leung R, Sebire NJ, et al. Extrarenal rhabdoid tumours outside the central nervous system in infancy. Pediatr Radiol. 2009;39(8):817–822.
- Geramizadeh B, Nikeghbalian S, Abolghasem-Hosseini S. Primary malignant rhabdoid tumor of the stomach, a rare case report and review of literature. J Gastrointest Cancer. 2010;41(4):269–271.
- Mazzocchi M, Chiummariello S, Bistoni G, et al. Extrarenal malignant rhabdoid tumour of the heel—a case report. Anticancer Res. 2005;25(6C):4573–4576.
- Ng WC, Leong HT, Ma KF, et al. Malignant rhabdoid tumour of the oesophagus: a case report. J Clin Pathol. 2003 Sep;56(9):713–714.
- Wu X, Dagar V, Algar E, et al. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour. Pathology. 2008;40(7):664–670.
- Madigan CE, Armenian SH, Malogolowkin MH, et al. Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience. Cancer. 2007;110(9):2061–2066.
- Morgenstern DA, Gibson S, Brown T, et al. Clinical and pathological features of paediatric malignant rhabdoid tumours. Pediatr Blood Cancer. 2010;54(1):29–34.
- Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer. 1978;41(5):1937–1948.
- Tomlinson GE, Breslow NE, Dome J, et al. Rhabdoid tumour of the kidney in the National Wilms tumour study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005;23(30):7641–7645.
- Gururangan S, Bowman LC, Parham DM, et al. Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer. 1993;71(8):2653–2659.
- Rosson GB, Vincent TS, Oswald BW, et al. Drug resistance in malignant rhabdoid tumor cell lines. Cancer Chemother Pharmacol. 2002;49(2):142–148.
- Puri DR, Meyers PA, Kraus DH, et al. Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumors. Pediatr Blood Cancer. 2008;50(1):167–169.
- Garrè ML, Tekautz T. Role of high-dose chemotherapy (HDCT) in treatment of atypical teratoid/rhabdoid tumors (AT/RTs). Pediatr Blood Cancer. 2010;54(4):647–648.
- Sultan I, Qaddoumi I, Rodríguez-Galindo C, et al. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors. Pediatr Blood Cancer. 2010;54(1):35–40.
- Benesch M, Bartelheim K, Fleischhack G, et al. High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB). Bone Marrow Transplant. 2014;49(3):370–375.
- Waldron PE, Rodgers BM, Kelly MD, et al. Successful treatment of a patient with stage IV rhabdoid tumor of the kidney: case report and review. J Pediatr Hematol Oncol. 1999;21(1):53–57.
- Seeringer A, Bartelheim K, Kerl K, et al. Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registry. Klin Padiatr. 2014 Mar 14 [Epub ahead of print].